论文部分内容阅读
目的:观察桂哌齐特对脑梗死的治疗效果。方法:128例脑梗死病人,随机分为治疗组和对照组,治疗组用桂哌齐特注射液160mg,静滴,qd;对照组用血塞通注射液500mg,静滴,qd;疗程28d,观察疗效。结果:治疗前后神经功能缺损评分结果显示:两组均有降低,但治疗组降低更明显,与对照组比较有统计学差异(P<0.01);治疗组和对照组总有效率分别为87.5%,70.3%,治疗组明显高于对照组(P<0.01);治疗前后两组血液流变学各项指标均有改善,治疗组改善更明显(P<0.01)。结论:桂哌齐特治疗脑梗死疗效显著,无明显不良反应。
Objective: To observe the effect of cinepazide on cerebral infarction. Methods: 128 patients with cerebral infarction were randomly divided into treatment group and control group, the treatment group with cinepazide 160mg, intravenous infusion, qd; control group with Xuesaitong injection 500mg, intravenous infusion, qd; course of treatment 28d , Observe the effect. Results: The results of neurological deficit score before and after treatment showed that both groups were decreased, but the treatment group decreased more obviously compared with the control group (P <0.01); The total effective rates of the treatment group and the control group were 87.5% , 70.3% in the treatment group was significantly higher than that in the control group (P <0.01). The indexes of hemorheology in both groups were improved before and after treatment, and the improvement in the treatment group was more obvious (P <0.01). Conclusion: Cinepazide treatment of cerebral infarction significant effect, no significant adverse reactions.